In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...

The following is a summary of “Underutilized treatments for patients with refractory cancer pain: A qualitative study assessing the use of intrathecal drug delivery devices in the United Kingdom ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...

The two medications are Fentanyl, an opioid, and low-dose Ketamine, an anesthetic. The study, beginning in the fall of 2024 is led by Daniel Wolfson, MD, associate professor of Emergency Medicine, and ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology,” published in the January 2025 issue of Pain by ...

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and ...

Doctors often use different methods to help people manage chronic pain. One common approach is prescribing opioid painkillers. These medicines can be very effective, but they also come with serious ...